These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35265931)

  • 1. Risk factor management of atrial fibrillation using mHealth: The Atrial Fibrillation - Helping Address Care with Remote Technology (AF-HEART) Pilot Study.
    Mitrani LR; Goldenthal I; Leskowitz J; Wan EY; Dizon J; Saluja D; Creber RM; Turchioe MR; Sciacca RR; Garan H; Hickey KT; Korner J; Biviano AB
    Cardiovasc Digit Health J; 2022 Feb; 3(1):14-20. PubMed ID: 35265931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile Electrocardiogram Monitoring and Health-Related Quality of Life in Patients With Atrial Fibrillation: Findings From the iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology (iHEART) Study.
    Caceres BA; Hickey KT; Bakken SB; Biviano AB; Garan H; Goldenthal IL; Koleck TA; Masterson-Creber R; Turchioe MR; Jia H
    J Cardiovasc Nurs; 2020; 35(4):327-336. PubMed ID: 32015256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of a Remote Cardiac Rehabilitation Program for Patients Undergoing Atrial Fibrillation Ablation: Pilot Study.
    Misra S; Niazi K; Swayampakala K; Blackmon A; Lang M; Davenport E; Saxonhouse S; Fedor J; Powell B; Thompson J; Holshouser J; Mehta R
    JMIR Cardio; 2023 Dec; 7():e49345. PubMed ID: 38096021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.
    Essebag V; Azizi Z; Alipour P; Khaykin Y; Leong-Sit P; Sarrazin JF; Sturmer M; Morillo C; Terricabras M; Amit G; Roux JF; Patterson S; Verma A
    Europace; 2020 Jul; 22(7):1017-1025. PubMed ID: 32531030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
    Gupta D; Vijgen J; Potter T; Scherr D; Van Herendael H; Knecht S; Kobza R; Berte B; Sandgaard N; Albenque JP; Széplaki G; Stevenhagen Y; Taghji P; Wright M; Duytschaever M
    Heart; 2021 Aug; 107(16):1296-1302. PubMed ID: 33952593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.
    Boersma L; Koźluk E; Maglia G; de Sousa J; Grebe O; Eckardt L; Hokanson RB; Hemingway LA; Ostern E; Park HS; Rovaris G; Arribas F; Scharf C; Csanádi Z; Arenal Á; Laurenzi F; Klaver M; Goette A
    Europace; 2020 Jun; 22(6):888-896. PubMed ID: 32219388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation for atrial fibrillation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Atrial Fibrillation Health Literacy Information Technology System: Pilot Assessment.
    Magnani JW; Schlusser CL; Kimani E; Rollman BL; Paasche-Orlow MK; Bickmore TW
    JMIR Cardio; 2017; 1(2):e7. PubMed ID: 29473644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the quality of life of patients with persistent or long-standing persistent atrial fibrillation after hybrid ablation.
    Osmancik P; Budera P; Talavera D; Herman D; Vesela J; Prochazkova R; Rizov V; Kacer P
    J Interv Card Electrophysiol; 2020 Apr; 57(3):435-442. PubMed ID: 31001766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Utility of mHealth ECG Heart Monitoring for the Detection and Management of Atrial Fibrillation in Clinical Practice.
    T Hickey K; B Biviano A; Garan H; Sciacca RR; Riga T; Warren K; Frulla AP; Hauser NR; Wang DY; Whang W
    J Atr Fibrillation; 2017; 9(5):1546. PubMed ID: 29250277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome.
    Raine D; Langley P; Shepherd E; Lord S; Murray S; Murray A; Bourke JP
    Open Heart; 2015; 2(1):e000302. PubMed ID: 26380100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study.
    Feyz L; Theuns DA; Bhagwandien R; Strachinaru M; Kardys I; Van Mieghem NM; Daemen J
    Clin Res Cardiol; 2019 Jun; 108(6):634-642. PubMed ID: 30413869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?
    Dorian P; Burk C; Mullin CM; Bubien R; Godejohn D; Reynolds MR; Lakkireddy DR; Wimmer AP; Bhandari A; Spertus J
    Am Heart J; 2013 Aug; 166(2):381-387.e8. PubMed ID: 23895823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-Demand Mobile Health Infrastructure for Remote Rhythm Monitoring within a Wait-and-See Strategy for Recent-Onset Atrial Fibrillation: TeleWAS-AF.
    Pluymaekers NAHA; van der Velden RMJ; Hermans ANL; Gawalko M; Buskes S; Keijenberg JJHMW; Vorstermans B; Crijns HJGM; Hendriks JM; Linz D
    Cardiology; 2021; 146(3):392-396. PubMed ID: 33735889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a nurse-led limited risk factor modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Yaeger A; Keenan BT; Cash NR; Parham T; Deo R; Frankel DS; Schaller RD; Santangeli P; Nazarian S; Supple GE; Arkles J; Kumareswaran R; Hyman MC; Riley MP; Garcia FC; Lin D; Epstein AE; Callans DJ; Mora JI; Amaro A; Schwab R; Pack A; Marchlinski FE; Dixit S
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):423-431. PubMed ID: 31916273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usability and effect of an mHealth disease management platform on the quality of life of patients with paroxysmal atrial fibrillation - The emPOWERD-AF study.
    Lazaridis C; Bakogiannis C; Mouselimis D; Tsarouchas A; Antoniadis AP; Triantafyllou K; Fragakis N; Vassilikos VP
    Health Informatics J; 2022; 28(4):14604582221139053. PubMed ID: 36398411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.
    Ikemura N; Kohsaka S; Kimura T; Ueda I; Katsumata Y; Nishiyama T; Aizawa Y; Tanimoto K; Momiyama Y; Akaishi M; Mitamura H; Fukuda K; Spertus JA; Takatsuki S
    JAMA Netw Open; 2019 Mar; 2(3):e191145. PubMed ID: 30924896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation.
    Mohanty S; Mohanty P; Natale V; Trivedi C; Gianni C; Burkhardt JD; Sanchez JE; Horton R; Gallinghouse GJ; Hongo R; Beheiry S; Al-Ahmad A; Di Biase L; Natale A
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):246-253. PubMed ID: 29171116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
    Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
    JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nurse-Led Limited Risk Factor Modification Program to Address Obesity and Obstructive Sleep Apnea in Atrial Fibrillation Patients.
    Yaeger A; Cash NR; Parham T; Frankel DS; Deo R; Schaller RD; Santangeli P; Nazarian S; Supple GE; Arkles J; Riley MP; Garcia FC; Lin D; Epstein AE; Callans DJ; Marchlinski FE; Kolansky DM; Mora JI; Amaro A; Schwab R; Pack A; Dixit S
    J Am Heart Assoc; 2018 Dec; 7(23):e010414. PubMed ID: 30571593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.